Australia vs Belgium: Access to anti-retroviral drugs, male
Australia
88.0%
in 2023
Belgium
88.0%
in 2023
Australia rank
23rd
Belgium rank
23rd
Access to anti-retroviral drugs, male over time
- Australia
- Belgium
How they compare
Australia currently reports 88.0% against 88.0% in Belgium, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Australia ahead.
Australia ranks 23rd and Belgium ranks 23rd of 141 countries.
Across the 3 decades both report, Australia averaged higher in 1 and Belgium in 2.
Head to head by decade
| Decade | Australia | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.1% | 50.5% | 3.6% | Australia |
| 2010s | 76.6% | 83.6% | 7.0% | Belgium |
| 2020s | 86.5% | 87.8% | 1.2% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Australia or Belgium?
- Australia, at 88.0% against 88.0% in Belgium as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Australia and Belgium?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Belgium?
- 24 years are reported by both, from 2000 to 2023.
- How do Australia and Belgium rank globally for access to anti-retroviral drugs, male?
- Australia ranks 23rd and Belgium ranks 23rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.